AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
M R an a Flue Vaccines
This journey started in january this year and was devoted to the development of an e, well tolerated and effective covet nineteen vaxcine following the highest scientific and ethical standards. The technology behind the spek seen, the messenger ana technology and the rexine candidates have beendevelopedin germany. Biinte received a hundred and twenty million in up front equity and near term research payments for m r n a base flue vaccines.